Mice deficient in Fas antigen as a consequence of inheriting Faslpr, fail to initiate apoptosis and eliminate potentially autoreactive T cells. Introduction of Faslpr into the MRL background leads to progressive autoimmune renal injury. Faslpr does not invariably cause severe autoimmune kidney disease, however, as the interaction of Faslpr with non-autoimmune genetic backgrounds does not induce renal injury. Rather, Faslpr converts mild, indolent kidney injury, in mice with the MRL background (MRL-++) into rapid and severe disease. Macrophage growth factor, CSF-1, is expressed in MRL-Faslpr and MRL-++ mice prior to renal injury. The investigators can circumvent the requirement for the MRL genes and incite renal injury in non-autoimmune C3H-Faslpr mice by directly introducing CSF-1 into the kidney. By comparison, CSF-1 does not incite renal injury in normal mice. The investigators hypothesize that select autoreactive T cells are required for CSF-1 incited autoimmune kidney disease. They propose to examine renal injury in two systems in the MRL strains. One system uses a gene transfer approach that delivers CSF-1 into the kidney and incites local, antibody-independent, interstitial nephritis. The other system is spontaneous disease composed of interstitial, glomerular, and perivascular inflammation. They will determine the T cell phenotypes associated with CSF-1-incited renal injury, and establish whether T cells in CSF-1-incited and spontaneous renal injury are distinctive. They will compare the CSF-1-induced kidney infiltrating T cells in Faslpr strains that are prone (MRL-Faslpr) or resistant (DBA/2-Faslpr, C3H-Faslpr) to renal injury. They will determine the T cells required for CSF-1-incited autoimmune renal injury through genetic deletion of selected T cell subsets. They will analyze MRL-Faslpr and MRL-++ strains crossed with T cell-deficient """"""""knockout"""""""" mice lacking a/b TCR, g/d TCR, a/b and g/d TCR, CD4 T cells, CD8 and double negative T cells, as well as CD40 ligand. These studies will specifically address the impact of alterations in the T cell repertoire on kidney disease. Finally, the investigators will identify T cells responsible for CSF-1-incited autoimmune renal injury using adoptive transfer studies. They will determine which T cell subsets are sufficient to incite renal destruction by introducing select T cells into MRL-++, and T cell-deficient MRL-Faslpr kidneys without disease, and test the impact on renal injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK052369-01A1
Application #
2487809
Study Section
Pathology A Study Section (PTHA)
Project Start
1998-02-01
Project End
2003-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Menke, Julia; Hsu, Mei-Yu; Byrne, Katelyn T et al. (2008) Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice. J Immunol 181:7367-79
Lucas, Julie A; Menke, Julia; Rabacal, Whitney A et al. (2008) Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J Immunol 181:2513-21
Menke, Julia; Zeller, Geraldine C; Kikawada, Eriya et al. (2008) CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol 19:1177-89
Menke, Julia; Lucas, Julie A; Zeller, Geraldine C et al. (2007) Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J Immunol 179:7466-77
Kelley, Vicki Rubin (2007) Leukocyte-renal epithelial cell interactions regulate lupus nephritis. Semin Nephrol 27:59-68
Zeller, Geraldine C; Hirahashi, Junichi; Schwarting, Andreas et al. (2006) Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. J Am Soc Nephrol 17:122-30
Schwarting, Andreas; Paul, Kathrin; Tschirner, Stefan et al. (2005) Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice. J Am Soc Nephrol 16:3264-72
Lenda, Deborah M; Stanley, E Richard; Kelley, Vicki R (2004) Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol 173:4744-54
Lenda, Deborah M; Kikawada, Eriya; Stanley, E Richard et al. (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170:3254-62
Kelley, Vicki Rubin; Rovin, Brad H (2003) Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 24:411-21

Showing the most recent 10 out of 19 publications